PDF-HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include a

VITROL naltrexone for extendedrelease injectable suspension for intramuscular useInitial US ApprovalRECENT MAJOR CHANGESDosage and Administration 22 032021Warnings and Precautions 51 032021INDICATIO. See full prescribing information for BIOTHRAX BIOTHRAX Anthrax Vaccine Adsorbed Suspension for Intramuscular or Subcutaneous Injection Initial US Approval 1970 RECENT MAJOR CHANGES DOSAGE AND ADMINISTRATION 21 May2012 INDICATIONS AND USAGE Bacillu See full prescribing information for Ferric Citrate Ferric Citrate ablet containing 210 mg of ferric iron equivalent to 1 g ferric citrate for ral se Initial U Approval 2014 INDICATIONS AND USAGE Ferric Citrate s a phosphate binder indicated for See full prescribing information for LATISSE LATISSE bimatoprost ophthalmic solution 003 Initial US Approval 2001 INDICATIONS AND USAGE LATISSE is a prostaglandin analog indicated to treat hypotrichosis of the eyelashes by increasing their growth FULL PRESCRIBING INFORMATION: CONTENTS* INDICATIONS AND USAGE1.1Alzheimer What’s different about paediatric prescribing. Children are just . small adults. NOT!. Vary in their developmental stages. Pre-term, neonates, infants, children, adolescents. Dynamic anatomy and physiology. Dr L . Varadhan. C2017 Meeting – Doctor as Practitioner. 1. st. June 2016. Agenda. Current teaching offered year-wise in hospitals. What is expected at the end of academic years. Broad overview of changes needed. Anthony Oxley – Head of Pharmacy. The Driver for Implementing EPMA?. Mental Health, Learning Disability and Community Health Services.. Prince2 Project . JAC User. Leicestershire Partnership NHS Trust. Senior Lecturer . Leeds Beckett University . Miranda Thew. Aims. Public health agenda . Understanding Social Prescribing. A Role less travelled! . Exploring ideas for an occupational therapist role. . Outline. Antibiotic prescribing across the U.S.. What is known about antibiotic prescribing in New York State. CDC’s Get Smart program. Our antibiotic prescribing project. Resources. Slide from CDC Get Smart Program. 5.1Hypersensitivity5.2Exogenous Ochronosis5.3Effects on Endocrine System5.4Cutaneous ReactionsADVERSE REACTIONSUSE IN SPECIFIC POPULATIONS8.1Pregnancy8.3NursingMothers8.4Pediatric Use8.5Geriatric Use1 WARNING: LOSS OF BONE MINERAL DENSITY Women who use Depo-Provera Contraceptive Injection may lose significant bone mineral density. Bone loss is greater with increasing duration of use and may not be __________________________________________________________________ FULL PRESCRIBING INFORMATION INDICATIONS AND USAGE Jakafi is indicated for treatment of patients with intermediate or high-risk Limitation of Use Should only be used for acute treatment periods up to two or three weeks (1)------------------------DOSAGE AND ADMINISTRATION------------------- DESCRIPTIONCLINCIAL PHARMACOLOGY12.1 Reference ID 4330857FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE TOBI is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudom